Abbott agrees to pay $12 mln fine in China price fixing probe
SHANGHAI Aug 7 (Reuters) - Abbott Laboratories has agreed to pay a fine amounting to around $12 million, a spokeswoman said in emailed comments on Wednesday, following Chinese investigations into price fixing and anti-competitive practices by foreign baby formula makers.
China's top economic planner fined six companies a total of 670 million yuan ($109.45 million), China's state media reported earlier on Wednesday, including Abbott, Mead Johnson, Dumex, Fonterra, Friesland and Biostime.
- U.S., Arab partners launch first strikes on IS in Syria
- Qatar adamant it will host 2022 World Cup despite doubts
- Ebola could strike 20,000 in six weeks, 'rumble on for years': study
- Argentina's Fernandez to meet billionaire investor Soros in New York
- More Americans than ever have never married: survey